TRIGLIMISAVE 1 HS + (Glimepiride (1mg) + Metformin (1000mg) + Pioglitazone (15mg))

Triglimisave 1 HS+ Tablet SR is a pharmaceutical combination designed to assist in managing blood glucose levels. This medication is intended for use alongside dietary modifications and physical activity, aimed at enhancing glycemic control for individuals diagnosed with type 2 diabetes mellitus. Its mode of action facilitates the effective utilization of insulin, thereby contributing to a reduction in overall blood sugar levels. It is important to adhere to the dosing instructions provided by your healthcare professional regarding the duration and quantity of the medication. Taking the tablet with food is recommended to minimize the risk of gastrointestinal discomfort. In the event of a missed dose, it should be taken as promptly as possible except when it is close to the time for the subsequent dose, in which case the missed dose should be omitted to maintain the regular dosing schedule; doubling doses should be avoided to prevent potential adverse effects, including hypoglycemia. Monitoring blood sugar levels is essential, especially since some users may experience hypoglycemia when this medication is combined with other diabetes treatments, alcohol, or if meals are skipped. Other potential side effects may include nausea, diarrhea, abdominal pain, headaches, bone fractures, and respiratory infections. Prior to initiating this therapy, it is crucial to disclose any history of renal, hepatic, or cardiovascular conditions to your doctor. Pregnant and lactating individuals are advised to seek medical guidance before usage, and kidney function tests may be conducted as a precautionary measure. Caution is advised regarding alcohol consumption due to the increased risk of side effects.